Test Price
2,800 AED✅ Home Collection Available
ATP1A3 Gene (DYT12) Sequencing Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
Executive Summary
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Complimentary Telephonic Post-Test Clinical Result Interpretation by genetic counsellors.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Facility License: 1143
ISO 9001:2015 Cert: INT/EGQ/2509DA/3139
Turnaround Time: 3 – 4 Weeks
Sample Options: Whole Blood (EDTA/DNA FTA Card) or Extracted DNA
Price: 2800 AED (all-inclusive)
Test Overview & Methodology
The ATP1A3 NGS test sequences the entire coding region of the gene associated with DYT12 dystonia and alternating hemiplegia of childhood (AHC). This advanced next‑generation sequencing (NGS) technology replaces older single‑exon methods with 99.9% coverage uniformity, delivering a molecular diagnosis in 3–4 weeks.
| Feature | Our Test (NGS – UAE DHA Certified) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Precision | 99.9% sensitivity & specificity – full gene coverage | ~90% for targeted hotspots, may miss deep intronic variants |
| Methodology | LC‑MS/MS validated NGS (Illumina NovaSeq) | Capillary electrophoresis (Sanger) |
| Turnaround | 3–4 weeks | 6–8 weeks (often outsourced) |
| Cost | 2800 AED – includes post‑test counselling | ~3500 AED (excl. interpretation) |
| Regulatory | ISO 9001:2015, DHA licensed, UAE PDPL compliant | Variable |
Physician Insight & Safety Protocols
"As a DHA‑licensed Consultant Medical Geneticist, I emphasize that a positive ATP1A3 result does not automatically dictate the clinical course; many carriers remain asymptomatic. Correlation with detailed neurological examination, family history, and functional outcomes is essential. Never stop or adjust prescribed medication without direct specialist consultation."
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Important Medication Advisory
🚨 Medication Advisory
Do not discontinue prescribed medication without consulting your doctor. Abrupt cessation of dopamine‑modulating drugs or muscle relaxants can trigger severe dystonic crisis or autonomic instability.
Exclusion Criteria & Emergency Red Flags
Exclusion Criteria:
- Inability to provide informed consent or legal guardian consent per Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Patients currently undergoing intensive plasmapheresis that may interfere with DNA integrity.
- Known coagulopathy unrelated to the condition under investigation.
Seek Emergency Care if you experience:
- Sudden severe generalized dystonia (“status dystonicus”)
- Autonomic instability: respiratory compromise, labile blood pressure, or hyperthermia
- Loss of ambulation or acute swallowing difficulty
This test is not a standalone diagnostic tool. Always follow the genetic counselling session and a comprehensive clinical assessment.
Patient FAQ & Clinical Guidance
1. What is the ATP1A3 gene test, and why might I need it?
This test identifies pathogenic variants in the ATP1A3 gene that cause DYT12 dystonia or alternating hemiplegia of childhood (AHC), enabling accurate diagnosis and family counselling.
2. How is the sample collected, and is a hospital visit required?
A certified phlebotomist performs a standard blood draw from your arm; alternatively, a fingerprick DNA FTA card can be used – all through DHA‑approved VIP mobile phlebotomy and temperature-controlled cold-chain home collection, available daily from 8 AM to 11 PM. No hospital visit is required.
3. Will my insurance cover the 2800 AED cost? What about data privacy?
We offer direct billing verification with all major UAE insurers; send your insurance card via WhatsApp to +971 54 548 8731 for instant coverage confirmation. All genetic data is secured under Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance & Data Privacy
DNA Labs UAE operates under DHA Facility License No. 1143. All genetic test results are processed with strict adherence to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Your data remains confidential and used solely for diagnostic purposes with your explicit consent.
Clinical & Logistical Metadata
| Test Name | ATP1A3 Gene (DYT12) Sequencing Test |
| Price (AED) | 2800 AED (all-inclusive) |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole Blood (EDTA/DNA FTA Card) or Extracted DNA |
| Methodology Used | Next-Generation Sequencing (NGS) – Illumina NovaSeq |
| ICD-10-CM Code | G24.0, G83.89 |
| LOINC Code | 55233-1 |
| DHA Facility License & Laboratory Address | DHA License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians